Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: Implication for Th17 lymphocytes-mediated allergic inflammation

Journal of Immunology

Volumn 180, Issue 8, 2008, Pages 5625-5635

  Cheung, Phyllis F Y ^a   Wong, Chun K ^b   Lam, Christopher W K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CHEMOKINE; CXCL1 CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; IL17F PROTEIN, HUMAN; INTERLEUKIN 1BETA; RECOMBINANT PROTEIN;

ALLERGIC DISEASE; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; DENDRITIC CELL; EOSINOPHIL; HUMAN; MACROPHAGE; PRIORITY JOURNAL; PROTEIN SECRETION; TH17 CELL; CELL CULTURE; HELPER CELL; IMMUNOLOGY; INFLAMMATION; METABOLISM; SIGNAL TRANSDUCTION;

CELLS, CULTURED; CHEMOKINES; CYTOKINES; EOSINOPHILS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-23; INTERLEUKIN-6; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 45949090104     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.8.5625     Document Type: Article

References (48)

1. Kawaguchi, M., M. Adachi, N. Oda, F. Kokubu, and S. K. Huang. 2004. IL-17 cytokine family. J. Allergy Clin. Immunol. 114: 1265-1273.
2. Kolls, J. K., and A. Linden. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
3. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
4. Molet, S., Q. Hamid, F. Davoine, E. Nutku, R. Taha, N. Page, R. Olivenstein, J. Elias, and J. Chakir. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108: 430-438.
5. Kawaguchi, M., L. F. Onuchic, X. D. Li, D. M. Essayan, J. Schroeder, H. Q. Xiao, M. C. Liu, G. Krishnaswamy, G. Germino, and S. K. Huang. 2001. Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J. Immunol. 167: 4430-4435.
6. Hizawa, N., M. Kawaguchi, S. K. Huang, and M. Nishimura. 2006. Role of interleukin-17F in chronic inflammatory and allergic lung disease. Clin. Exp. Allergy 36: 1109-1114.
7. H2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13: 139-145.
8. Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5: 521-531.
9. McKenzie, B. S., R. A. Kastelein, and D. J. Cua. 2006. Understanding the IL- 23-IL-17 immune pathway. Trends Immunol. 27: 17-23.
10. Bettelli, E., M. Oukka, and V. K. Kuchroo. 2007. T (H) -17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8: 345-350.
11. Fujiwara, M., K. Hirose, S. Kagami, H. Takatori, H. Wakashin, T. Tamachi, N. Watanabe, Y. Saito, I. Iwamoto, and H. Nakajima. 2007. T-bet inhibits both TH2 cell-mediated eosinophil recruitment and TH17 cell-mediated neutrophil recruitment into the airways. J. Allergy Clin. Immunol. 119: 662-670.
12. Bullens, D. M., E. Truyen, L. Coteur, E. Dilissen, P. W. Hellings, L. J. Dupont, and J. L. Ceuppens. 2006. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir. Res. 7: 135.
13. Pirhonen, J., S. Matikainen, and I. Julkunen. 2002. Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J. Immunol. 169: 5673-5678.
14. Happel, K. I., M. Zheng, E. Young, L. J. Quinton, E. Lockhart, A. J. Ramsay, J. E. Shellito, J. R. Schurr, G. J. Bagby, S. Nelson, and J. K. Kolls. 2003. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170: 4432-4436.
15. Aggarwal, S., N. Ghilardi, M. H. Xie, F. J. De Sauvage, and A. L. Gurney. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278: 1910-1914.
16. Humbles, A. A, C. M. Lloyd, S. J. McMillan, D. S. Friend, G. Xanthou, E. E. McKenna, S. Ghiran, N. P. Gerard, C. Yu, S. H. Orkin, and C. Gerard. 2004. A critical role for eosinophils in allergic airways remodeling. Science 305: 1776-1779.
17. Walsh, G. M. 2001. Eosinophil granule proteins and their role in disease. Curr. Opin. Hematol. 8: 28-33.
18. Nelson, H. S. 2007. Advances in upper airway diseases and allergen immunotherapy. J. Allergy Clin. Immunol. 119: 872-880.
19. Weller, P. F. 1997. Human eosinophils. J. Allergy Clin. Immunol. 100: 283-287.
20. Wong, C. K., W. K. Ip, and C. W. Lam. 2004. Biochemical assessment of intracellular signal transduction pathways in eosinophils: implications for pharmacotherapy. Crit. Rev. Clin. Lab. Sci. 24: 165-186.
21. Wong, C. K., P. F. Cheung, W. K. Ip, and C. W. Lam. 2005. Interleukin-25- induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun. N-terminal kinase, and nuclear factor-κB. Am. J. Respir. Cell Mol. Biol. 33: 186-194.
22. Cheung, P. F., C. K. Wong, W. K. Ip, and C. W. Lam. 2006. IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation. Allergy 61: 878-885.
23. Chang, S. H., H. Park, and C. Dong. 2006. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J. Biol. Chem. 281: 35603-35607.
24. Qian, Y., C. Liu, J. Hartupee, C. Z. Altuntas, M. F. Gulen, D. Jane-Wit, J. Xiao, Y. Lu, N. Giltiay, J. Liu, et al. 2007. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8: 247-256.
25. Lankford, C. S., and D. M. Frucht. 2003. A unique role for IL-23 in promoting cellular immunity. J. Leukocyte Biol. 73: 49-56.
26. Moseley, T. A., D. R. Haudenschild, L. Rose, and A. H. Reddi. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14: 155-174.
27. Kuestner, R. E., D. W. Taft, A. Haran, C. S. Brandt, T. Brender, K. Lum, B. Harder, S. Okada, C. D. Ostrander, J. L. Kreindler, et al. 2007. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J. Immunol. 179: 5462-5473.
28. Hymowitz, S. G., E. H. Filvaroff, J. P. Yin, J. Lee, L. Cai, P. Risser, M. Maruoka, W. Mao, J. Foster, R. F. Kelley, et al. 2001. IL-17s adopt a cysteine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 20: 5332-5341.
29. Parham, C, M. Chirica, J. Timans, E. Vaisberg, M. Travis, J. Cheung, S. Pflanz, R. Zhang, K. P. Singh, F. Vega, et al. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168: 5699-5708.
30. Jones, C. E., and K. Chan. 2002. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-α, and granulocyte-colony- stimulating factor by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 26: 748-753.
31. Starnes, T., M. J. Robertson, G. Sledge, S. Kelich, H. Nakshatri, H. E. Broxmeyer, and R. Hromas. 2001. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J. Immunol. 167: 4137-4140.
32. Kleinschek, M. A., U. Muller, S. J. Brodie, W. Stenzel, G. Kohler, W. M. Blumenschein, R. K. Straubinger, T. McClanahan, R. A. Kastelein, and G. Alber. 2006. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J. Immunol. 176: 1098-1106.
33. Romagnani, S. 2002. Cytokines and chemoattractants in allergic inflammation. Mol. Immunol. 38: 881-885.
34. Ferreira, M. A. 2003. Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies. Mediat. Inflamm. 12: 259-267.
35. Wong, C. K., and C. W. Lam. 2003. Clinical applications of cytokine assays. Adv. Clin. Chem. 37: 1-46.
36. Lukacs, N. W., and K. K. Tekkanat. 2000. Role of chemokines in asthmatic airway inflammation. Immunol. Rev. 177: 21-30.
37. Wu, Q., R. J. Martin, J. G. Rino, R. Breed, R. M. Torres, and H. W. Chu. 2007. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect. 9: 78-86.
38. Molet, S., Q. Hamid, F. Davoine, E. Nutku, R. Taha, N Pagé, R. Olivenstein, J. Elias, and J. Chakir. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108: 430-438.
39. Lacy, P., and R. Moqbel. 2000. Eosinophil cytokines. Chem. Immunol. 76: 134-155.
40. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949.
41. Fedele, G., P. Stefanelli, F. Spensieri, C. Fazio, P. Mastrantonio, and C. M. Ausiello. 2005. Bordetella pertussis-infected human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization and interleukin-23 expression. Infect. Immun. 73: 1590-1597.
42. Underwood, D. C, R. R. Osborn, C. J. Kotzer, J. L. Adams, J. C. Lee, E. F. Webb, D. C. Carpenter, S. Bochnowicz, H. C. Thomas, D. W. Hay, and D. E. Griswold. 2000. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J. Pharmacol. Exp. Ther. 293: 281-288.
43. Wong, C. K., W. K. Ip, and C. W. Lam. 2003. Interleukin-3, -5, and granulocyte macrophage colony-stimulating factor-induced adhesion molecule expression on eosinophils by p38 mitogen-activated protein kinase and nuclear factor-κB. Am. J. Respir. Cell Mol. Biol. 29: 133-147.
44. Wong, C. K., P. F. Cheung, W. K. Ip, and C. W. Lam. 2007. Intracellular signaling mechanisms regulating Toll-like receptor-mediated activation of eosinophils. Am. J. Respir. Cell Mol. Biol. 37: 85-96.
45. Ballantyne, S. J., J. L. Barlow, H. E. Jolin, P. Nath, A. S. Williams, K. F. Chung, G. Sturton, S. H. Wong, and A. N. McKenzie. 2007. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J. Allergy Clin. Immunol. 120: 1324-1331.
46. Tamachi, T., Y. Maezawa, K. Ikeda, S. Kagami, M. Hatano, Y. Seto, A. Suto, K. Suzuki, N. Watanabe, Y. Saito, et al. 2006. IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice. J. Allergy Clin. Immunol. 118: 606-614.
47. Kaminska, B. 2005. MAPK signalling pathways as molecular targets for antiinflammatory therapy: from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta 1754: 253-262.
48. Henderson, W. R. Jr., E. Y. Chi, J. L. Teo, C. Nguyen, and M. Kahn. 2002. A small molecule inhibitor of redox-regulated NF-κB and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model. J. Immunol. 169: 5294-5299.